Investigating how to reduce alcohol use and improve HIV outcomes in patients.
Zambia Alabama HIV Alcohol Comorbidities Program (ZAMBAMA)
This study is looking to help people living with HIV who also have issues with alcohol by trying out a new treatment method in clinics in Zambia and Alabama, aiming to improve their overall health and see how different personal factors might influence how well the treatment works.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-10915735 on NIH RePORTER |
What this research studies
The Zambia Alabama HIV Alcohol Comorbidities Program (ZAMBAMA) aims to help individuals with HIV who also struggle with unhealthy alcohol use. This research will test a treatment approach called the Common Elements Treatment Approach (CETA) in under-resourced HIV clinics in Zambia and Alabama. By integrating screening and treatment for both HIV and alcohol use, the program seeks to improve health outcomes for patients. The research will also explore how different factors, such as demographics and comorbidities, affect treatment success.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults over 21 years old who are living with HIV and have issues with unhealthy alcohol consumption.
Not a fit: Patients who do not have HIV or do not struggle with alcohol use may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved health outcomes for patients living with HIV who also consume alcohol excessively.
How similar studies have performed: Previous research has shown promise in using integrated treatment approaches for managing comorbidities in HIV patients, suggesting potential success for this program.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Cropsey, Karen L — University of Alabama at Birmingham
- Study coordinator: Cropsey, Karen L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.